Vermont Hydro Projects Seek License Extensions on Otter Creek
Published Date: 12/23/2025
Notice
Summary
Green Mountain Power wants to extend the licenses for two hydroelectric projects on Otter Creek in Vermont. This means they can keep running these power plants longer without changing how much electricity they produce. If you live nearby or care about the environment, you have until January 20, 2026, to share your thoughts or get involved before any decisions are made.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Public Comment Deadline — Jan 20, 2026
You have until January 20, 2026, at 5:00 p.m. Eastern Time to file comments, protests, or motions to intervene about Green Mountain Power's applications for the Weybridge (P-2731-045) and Middlebury Lower (P-2737-028) projects. Filings can be made electronically via FERC's eFiling or eComment systems or by mail and must include the docket numbers.
License Extension Keeps Plants Operating to 2041
Green Mountain Power requests extending the Weybridge and Middlebury Lower licenses from July 31, 2031, to July 31, 2041 so the company can recoup rehabilitation costs. The request would allow the projects to continue operating without changing how much electricity they produce; the authorized installed capacity remains 3.0 megawatts.
Turbine Upgrade With Minimal Disturbance
The licensee plans turbine runner replacements at both projects and proposes replacing the Weybridge turbine runner; the upgrade would keep installed capacity at 3.0 megawatts but reduce the powerhouse maximum hydraulic capacity from 1,600 cubic feet per second to 1,590 cfs. All proposed construction at Weybridge would occur inside the existing powerhouse, be isolated from the river, use the existing access road, and would not require ground disturbance.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11881 — Venture Global CP2 LNG, LLC, Venture Global CP Express, LLC; Notice of Application and Establishing Intervention Deadline
Venture Global CP2 LNG and CP Express want to expand their LNG export terminal in Louisiana and the pipeline from Texas to Louisiana. This big project will boost LNG export capacity by 11.7 million tonnes per year and add pipeline capacity for 1,900 million cubic feet daily, costing about $826 million. If you’re interested, you’ve got until the intervention deadline to speak up or get involved!
2026-11880 — Rio Grande LNG Train 6, LLC; Notice of Application and Establishing Intervention Deadline
Rio Grande LNG Train 6, LLC wants to expand its Texas LNG terminal by adding a new liquefaction train and marine jetty, boosting production by over 6 million tonnes per year and allowing more LNG ships to dock. This means more energy and business for the area, but folks have a deadline to speak up or get involved. The project is moving fast, so keep an eye on the clock and your calendars!
2026-11846 — Combined Notice of Filings
The Federal Energy Regulatory Commission is reviewing new and updated natural gas pipeline rate filings that could change how much customers pay starting as soon as July 1, 2026. Pipeline companies like DCP Guadalupe and Transcontinental Gas are asking for rate changes or corrections, and the public has until late June or early August to share their thoughts. These updates affect energy companies and customers who rely on natural gas, with some changes already effective or coming soon.
2026-11879 — Northern Natural Gas Company; Notice of Application and Establishing Intervention Deadline
Northern Natural Gas Company wants to build new pipelines and a compressor station in New Mexico and Texas to boost gas delivery to a power plant and improve their system’s reliability. The project will cost about $105 million, and they’re asking to include these costs in their regular rates. If you’re interested, you need to act before the deadline to get involved in the decision.
2026-11878 — California Department of Water Resources; Notice of Availability and Adoption of Final Environmental Assessment
The California Department of Water Resources has shared its final environmental assessment, which looks at how a new water project might affect the environment. This update mainly impacts local communities and water users by ensuring the project is safe and eco-friendly. The assessment is now official, so the project can move forward without delays or extra costs.
2026-11782 — Combined Notice of Filings
The Federal Energy Regulatory Commission got several new filings about natural gas pipeline rates and refunds from companies like NextEra Energy and ETC Tiger Pipeline. These filings could change how much customers pay starting as soon as June or July 2026. If you want to speak up or get involved, you need to act before the deadlines in mid to late June.
Previous / Next Documents
Previous: 2025-23703 — Combined Notice of Filings
The Federal Energy Regulatory Commission got new filings from natural gas companies about rate changes and refunds. If you’re involved or interested, you have until late December or early January to comment or join the discussion. These updates could affect how much people pay or get refunded for natural gas services starting early 2026.
Next: 2025-23707 — Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
The FDA just released final guidance to help drug companies and FDA staff settle scientific disagreements through formal dispute resolution and hearings. This update affects anyone involved in drug reviews under Section 505G and aims to make the process clearer and fairer. The guidance is effective now, helping save time and avoid costly delays in drug approvals.